A drug's scientific name must be mentioned alongside its brand name in online ads that do not cite the proprietary name in running text equivalent to multiple pages, the FDA said in guidance on placement of drug names in promotional material. The guideline aims to address "problems stemming from obscuring the presentation of, or minimizing disclosure of, the established name" of medicines in marketing material, including electronic media.

Related Summaries